Abstract:Objective To study the clinical effect of the application of the interventional embolization of hepatic artery with gelatin sponge particles in the treatment of giant hepatic carcinoma. Methods 91 cases of patients with giant liver cancer were randomly divided into the study group and the control group. The control group only used the iodine oil emulsion in the treatment of hepatic artery interventional chemotherapy embolization. The study group used gelatin sponge particles and iodine oil emulsion combined with the implementation of hepatic arterial chemoembolization. The tumor necrosis rate,the tumor diameter,the level of the fetal protein,liver function,adverse reaction and survival of the follow-up period were compared. Results The tumor necrosis rate in the study group was significantly higher than that in the control group (P < 0. 05). The tumor diameter between two groups had no significant difference (P >0. 05). After 1 month treatment the tumor diameter were significantly reduced (P <0. 05),and the diameter of the tumor in the study group 3 months after treatment was reduced,but had no significant difference compared with 1 month treatment(P > 0. 05). The tumor diameter in the control group was in-creased 3 months after treatment,but there was no significant difference between before operation and 1 months after operation (P >0. 05). There was no significant difference of AFP between the two groups before and after treatment (P > 0. 05),and the two groups were better than before treatment (P <0. 05). The liver function showed no significant difference between the two groups before treatment. After treatment,CHE,ALB,ALT and AST were significantly decreased,and TBIL was not signifi-cantly changed. After treatment,ALB and CHE were significantly decreased, and the other indicators had no significant change. After treatment,the levels of ALT and AST in the study group were significantly higher than those in the control group after treatment,and there were no significant differences between the two groups. There was no significant difference in the in-cidence of adverse reactions between the two groups (P >0. 05). The survival rate of 3 and 6 months after treatment had no significant difference (P >0. 05). The survival rate of 9 months and 12 months after treatment was significantly higher than that of the control group (P < 0. 05). Conclusion Massive type hepatocellular carcinoma (HCC) implementation of he-patic artery interventional embolization with gelatin sponge particles combined with lipiodol emulsion can significantly improve the curative effect in the near future,prolong the survival time of the patients and no significant increase in adverse reactions compared with the simple application of lipiodol emulsion embolization.

Long-Term Outcomes of Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol-Bleomycin Emulsion

Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness

[Clinical Effect of Terminal Branches Portal Vein Embolization Combined with Transcatheter Arterial Chemoembolization on Liver Neoplasms].

Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results

Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?

Long-term outcomes of transarterial embolization with lipiodol–bleomycin emulsion plus polyvinyl alcohol particles versus the particles alone for large symptomatic focal nodular hyperplasia: a propensity score–matched analysis

Transarterial Bleomycin–Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma

Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma.

Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response

Oxaliplatin and 5-Fluorouracil Hepatic Infusion with Lipiodolized Chemoembolization in Large Hepatocellular Carcinoma.

Treatment of Giant Hepatic Carcinoma by Transcatheter Arterial Embolization with Gelatin Sponge Particles with Iodine Oil Emulsion

Long-Term Outcomes of Balloon TACE for HCC: An European Multicentre Single-Arm Retrospective Study

Transarterial Chemoembolization for Huge Hepatocellular Carcinoma with Diameter over Ten Centimeters: a Large Cohort Study

Preliminary Clinical Study of Transcatheter Arterial Chemoembolization with ContourSe Microspheres and Lipiodol in Patients with Large Hepatocellular Carcinoma

Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma

Safety and efficacy of transcatheter arterial chemoembolization plus early sequential percutaneous radiofrequency ablation for the treatment of large primary liver cancer with hepatitis B cirrhosis:a single-center experience

The Utility of Large Dosage Lipiodol Treatment in Huge Primary Hepatic Carcinoma: a Report of 47 Cases

Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of Large Hepatocellular Carcinoma

Lipiodol combined with drug-eluting beads versus drug-eluting beads alone for transarterial chemoembolization of hepatocellular carcinoma: a multicenter study

The Long-Term Efficacy of Combined Chemoembolization and Local Irradiation in the Treatment of Patients with Large Hepatocellular Carcinoma.